Benesch is pleased to announce that Intellectual Property Partner Charan Brahma has been named to theDaily Journal's2026 Top Intellectual Property Lawyers list. Charan focuses his practice on patent litigation and a range of intellectual property matters, primarily representing pharmaceutical and technology clients. With a strong trial focus, he works closely with clients to develop efficient litigation strategies aligned with their business objectives.
The annual list honors leading intellectual property attorneys whose recent work has significantly influenced the field, highlighting those who have delivered exceptional results in high‑stakes matters and helped shape the evolving landscape of IP law.
"Charan brings exceptional strategic insight to complex patent disputes," said Intellectual Property Practice Group Chair Michael Stovsky. "His ability to translate technical issues into clear, compelling arguments consistently drives successful outcomes for our clients."
Charan excels at navigating complex patent matters, developing compelling client narratives and tailored, case‑specific strategies. He is highly experienced in high‑stakes litigation involving both high‑tech and pharmaceutical matters and is often called upon to step into existing cases to refocus strategy, drive efficiency and advance progress toward clients' business objectives. He frequently handles matters where early, targeted pressure is critical to achieving swift resolution, streamlining discovery and sharpening strategic positioning ahead of trial.
He advises clients across a broad spectrum of patent and intellectual property disputes, including those involving pharmaceutical, software, communications networks, medical device, mechanical and biotechnology innovations. Charan represents clients through all stages of litigation, including trial, inter partes review and other PTAB proceedings and appeals. He also leverages his trial experience to counsel clients on IP portfolio development, provide pre‑litigation and freedom‑to‑operate analyses, prosecute high‑value patents across a range of technologies and support transactional due diligence involving key intellectual property assets.
See the full list here.